Delivery Order SPE2DB20D2002-SPE2DB22FL23G
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of BROMSITE 0.075% eye drops. The $4,112.11 firm-fixed-price contract has a completion date of November 30, 2021 and was awarded on November 29, 2021. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that maintains several Indefinite Delivery Contracts (IDCs) with the DLA and the...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,615.05 for the supply of 4556120380 - BROMSITE 0.075% EYE DROPS 5ML. The award was issued by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 2, 2022. The contract is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the supply of BROMSITE 0.075% EYE DROPS 5ML to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for a ceiling value of $2,846.00. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of March 3, 2023. This contract is not designated with a set-aside requirement, indicating open competition....
- This federal contract award, valued at $3,032.41, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BROMSITE 0.075% EYE DROPS 5ML, a pharmaceutical product. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and an Ultimate Completion Date of June 3, 2024. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BROMSITE 0.075% eye drops in 5mL bottles, with a ceiling value of $7,789.71 and a completion date of August 17, 2023. The contract has a firm fixed price pricing type and is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Bromsite 0.075% eye drops. The $6,604.74 firm fixed-price delivery order has a completion date of November 22, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Bromsite 0.075% eye drops. The contract has a ceiling value of $2,830.99 and an ultimate completion date of November 16, 2021. This award is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November...
- This federal contract award, with ID SPE2DB20D2002|SPE2DB21FL59L, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $21,404.50 fixed-price delivery order is for the supply of BROMSITE 0.075% eye drops, a pharmaceutical product, to support military and government healthcare programs. The contract is not designated under any set-aside program, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $8,586.50 delivery order is for the pharmaceutical product Bromsite 0.075% eye drops, 5 ml, and is priced on a firm fixed-price basis. The award has no set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various government...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,498.63 fixed-price delivery order is for the supply of BROMSITE 0.075% eye drops, a specialty pharmaceutical product. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB22FL23GDelivery Order
This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,577.96 firm fixed-price delivery order is for the supply of 4556402973 - BROMSITE 0.075% EYE DROPS 5ML. The contract has a completion date of March 1, 2022 and was awarded on February 28, 2022. No set-aside designation was used for this open competition contract. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds several significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical and the Department of Justice Federal Bureau of Investigation. These IDCs, valued at up to $999,999,999 and $750,000 respectively, enable the efficient procurement of a comprehensive range of pharmaceutical products and medical supplies to support military, veteran, and other federal healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.6k | 2/28/22 |